Home > Boards > US OTC > Medical - Drugs > Roche Holding Ltd. (RHHBY)

Breast Cancer As First Targeted Indication. Roche dominates

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Scorpion King Member Profile
Followed By 3
Posts 638
Boards Moderated 0
Alias Born 05/24/13
160x600 placeholder
Illumina, Roche Enter Partnership to Use Genomics for Medical Diagnosis Dow Jones News - 1/13/2020 1:14:00 PM
Bristol-Myers Squibb, Macy's, Grubhub: Stocks That Defined the Week Dow Jones News - 1/10/2020 6:33:00 PM
Sarepta Shares Gain After Licensing Deal With Roche Dow Jones News - 12/23/2019 7:48:00 AM
Drugmakers Turn to Data Mining to Avoid Expensive, Lengthy Drug Trials Dow Jones News - 12/23/2019 5:59:00 AM
Sensyne Health Signs AI Research Pact With Roche Dow Jones News - 12/23/2019 5:31:00 AM
Roche Enters Licensing Agreement With Sarepta Therapeutics for Gene Therapy Dow Jones News - 12/23/2019 2:25:00 AM
Genentech: Tecentriq/Cotellic/Zelboraf Combo Study Meets Primary Endpoint Dow Jones News - 12/13/2019 7:37:00 AM
Genentech: Subcutaneous Perjeta/Herceptin Combo Comparable to IV Dow Jones News - 12/12/2019 11:44:00 AM
Novartis: FDA Accepts Xolair sBLA for Nasal Polyps Dow Jones News - 12/11/2019 6:37:00 AM
Roche Approves Proposals for Board and Executive Committee Dow Jones News - 12/9/2019 2:50:00 AM
Roche Extends Tender Offer for Spark Therapeutics Dow Jones News - 12/9/2019 2:16:00 AM
FDA Approves Marketing of Roche Diagnostics MRSA Diagnostic Test Dow Jones News - 12/5/2019 1:10:00 PM
Genentech: FDA Approves Tecentriq Plus Chemotherapy for Some Non-Small Cell Lung Cancer Dow Jones News - 12/3/2019 7:21:00 PM
Genentech Gets FDA Priority Review for Risdiplam for Spinal Muscular Atrophy Dow Jones News - 11/25/2019 7:36:00 AM
FDA Accepts Avastin Biosimilar BLA From Biogen, Samsung BioLogics Venture Dow Jones News - 11/19/2019 8:45:00 AM
New Hope in the Battle Against Ovarian Cancer NetworkNewsWire - 11/5/2019 8:45:00 AM
Delivering Precision Medicine’s True Potential: Big Data, Artificial Intelligence Identify New Cancer Therapeutics NetworkNewsWire - 10/29/2019 8:45:00 AM
U.K.'s Competition Watchdog Opens Probe into Roche Takeover of Spark Therapeutics Dow Jones News - 10/22/2019 2:46:00 AM
Roche: Phase 3 Study of Tecentriq, Avastin Combination a Success Dow Jones News - 10/21/2019 1:44:00 AM
Roche Says Outlook Is Improving as Revenue Grows Dow Jones News - 10/16/2019 1:48:00 AM
Roche Holding: Results From Tecentriq Study in Bladder Cancer Positive Dow Jones News - 9/30/2019 11:20:00 AM
Genentech Gets FDA Approval for Rituxan in Children With Two Rare Blood Vessel Disorders Dow Jones News - 9/27/2019 2:32:00 PM
Genentech Says Data Positive From Tecentriq Lung Cancer Study Dow Jones News - 9/27/2019 11:20:00 AM
U.K. Regulator to Probe Roche's Acquisition of Spark Therapeutics Dow Jones News - 9/25/2019 2:54:00 AM
Gene Therapies with Potential to Conquer Tough-to-Tackle Breast Cancers NetworkNewsWire - 9/24/2019 8:45:00 AM
Scorpion King   Sunday, 06/09/13 09:44:02 AM
Re: None
Post # of 138 
Breast Cancer As First Targeted Indication. Roche dominates the breast cancer industry with its Herceptin and related products targeting HER-2 positive patients. Roche products only are designed for 20 percent of the breast cancer population, yet generate about $6 billion in sales annually. Sunshine Biopharma’s Adva-27a target a larger population.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
Current Price
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist